• ICU Medical held its annual shareholder meeting on May 13, 2026, clearing amendments that remove certain supermajority voting provisions in favor of a simple majority standard.
• Shareholders also backed a charter change granting holders of at least 25% of voting power the right to call a special meeting, while rejecting a separate advisory proposal that sought to set the threshold at 10%.
• A related bylaw restatement to implement the charter changes took effect on May 15, 2026, when the amended and restated certificate of incorporation was filed and the charter amendments became effective.
• Shareholders ratified Deloitte & Touche as independent auditor for the year ending Dec. 31, 2026.
• An adjournment authority to solicit additional proxies for the 25% special-meeting right was also approved, if needed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ICU Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000883984-26-000031), on May 18, 2026, and is solely responsible for the information contained therein.